
Client Industries
The healthcare industry is currently defined by a single word: Consolidation. Across the Mid-Atlantic, independent medical groups, health tech startups, and specialized providers are navigating a high-stakes environment of Private Equity (PE) buy-outs, complex regulatory hurdles, and shifting partnership dynamics.
Davis, Burch & Abrams provides the “Bold Advocacy” required to protect enterprise value in this landscape. We advise physician-owners, healthcare executives, and investors who need more than a compliance checklist—they need a strategy to navigate exits, resolve partnership “divorces,” and win high-stakes commercial disputes.

In healthcare, a legal decision is never just about a regulation. It is about how that regulation affects a multiple on EBITDA, a physician’s restrictive covenant, or the viability of a multi-million dollar acquisition.
We understand that for a medical group or health tech firm, the practice is also an asset. Our counsel is designed to protect that asset from the internal and external threats that arise during growth and transition.

Our team integrates M&A and Commercial Litigation expertise to address the unique pressures of the healthcare market. We focus on the areas that most directly impact the trajectory of a healthcare business:

We represent physician-owned practices and specialty groups in buy-side and sell-side transactions. This includes navigating Letter of Intent (LOI) negotiations, complex diligence, and the structural nuances of Private Equity “roll-ups.” We ensure that “Exit Economics” are protected through well-drafted earn-outs and indemnity structures.
When the relationship between physician-owners breaks down, the risk to the practice is existential. We handle high-stakes shareholder and member disputes involving breach of fiduciary duty, compensation disagreements, and “for cause” terminations. We move quickly to resolve these “internal wars” before they degrade patient care or devalue the business.
In a competitive talent market, the “Non-Compete” is a central battleground. We advise groups and executives on the enforcement and defense of restrictive covenants. We understand how Virginia’s evolving non-compete laws affect the mobility of high-value providers and the protection of patient bases.
We don’t just identify Stark Law or Anti-Kickback issues; we provide the business structures to navigate them. Our focus is on “Strategic Compliance”—ensuring that your corporate structure (including MSO/PC models) is robust enough to withstand the scrutiny of a sophisticated buyer’s diligence team.
We advise health tech companies on the intersection of data, delivery, and capital. From software-as-a-service (SaaS) agreements for health systems to navigating the legal risks of AI-integrated diagnostics, we provide the transactional backbone for healthcare innovation.
Healthcare HIPAA compliance is often tested when a business is growing, transacting, or already under stress. We advise healthcare companies on HIPAA policy requirements, privacy governance, business associate relationships, internal controls, and other data-handling issues that can create operational, transactional, or litigation risk.

From the hospital systems of Norfolk and Virginia Beach to the specialized medical corridors in Richmond’s West End and Midlothian, DBA understands the regional nuances of the Virginia healthcare market. We operate where the “business of medicine” happens—advising clients who are building the future of care in the 804 and 757.

We know that healthcare litigation and governance aren’t just legal issues; they are valuation issues.
If a partnership dispute or a breach of contract cannot be settled, we have the documented jury verdicts to back up our advocacy.
We understand the MSO model, the PC structure, and the reality of physician-compensation cycles.
In healthcare M&A, timing is everything. We provide the “Bold Efficiency” required to close without over-lawyering the process.
